Unique ID issued by UMIN | UMIN000025348 |
---|---|
Receipt number | R000029176 |
Scientific Title | The effect of a fermented green tea, Yamabuki Nadeshiko, on fasting blood glucose level |
Date of disclosure of the study information | 2016/12/21 |
Last modified on | 2019/06/25 11:25:00 |
The effect of a fermented green tea, Yamabuki Nadeshiko, on fasting blood glucose level
The effect of a fermented green tea on fasting blood glucose level
The effect of a fermented green tea, Yamabuki Nadeshiko, on fasting blood glucose level
The effect of a fermented green tea on fasting blood glucose level
Japan |
The healthy volunteers with pre-diabetes
Adult |
Others
NO
Our purpose is to investigate whether Yamabuki Nadeshiko, a fermented green tea, improve fasting blood glucose level in healthy volunteers with pre-diabetes.
Safety,Efficacy
fasting blood glucose level
HbA1c (NGSP)
A glucose tolerance test
1.Insulin, HOMA-IR, Glico albumin
2.Blood Adiponectin level
3.Blood pressure
4.Blood and physical test
5.Cytokines and biological markers for diabetes and cardiovascular diseases
Interventional
Parallel
Randomized
Individual
Double blind -all involved are blinded
Placebo
YES
YES
Institution is not considered as adjustment factor.
NO
Central registration
2
Prevention
Food |
Yamabuki Nadeshiko, a fermented green tea, 3g/day (1g/time) for 12 weeks
Placebo tea 3g/day (1g/time) for 12 weeks
20 | years-old | <= |
80 | years-old | > |
Male and Female
Fasting blood glucose levels from 100 mg/dL to 126 mg/dL
Blood glucose levels from 140 mg/dL to 200 mg/gL after two-hour 75-gram oral glucose tolerance test
1) HbA1c (NGSP) under 6.5%
2) Treatment for heart failure, myocardial infarction, malignant neoplasm, and the other diseases
3) Chronic diseases such as atrial fibrillation, arrhythmia, hepatopathy, nephropathy, cerebrovascular disease, rheumatism, diabetes, dyslipidemia, hypertension, and the others
4) Pregnancy, nursing, or a wish of pregnancy within next 6 months
5) The person who participates in other clinical trials at the time of this study entry
6) Smoker
7) Taking drugs, hyighly concentrated catechin-containing beverages, and a new supplement of effective for affecting blood glucose level
8) No agreement by documents
9) etc
50
1st name | |
Middle name | |
Last name | Tatsuya Morimoto |
University of Shizuoka
Division of Molecular Medicine, School of Pharmaceutical Sciences
52-1, Yata, Suruga, Shizuoka, Shizuoka, Japan
054-264-5763
morimoto@u-shizuoka-ken.ac.jp
1st name | |
Middle name | |
Last name | Tatsuya Morimoto |
University of Shizuoka
Division of Molecular Medicine, School of Pharmaceutical Sciences
52-1, Yata, Suruga, Shizuoka, Shizuoka, Japan
054-264-5763
yamabuki.shizuoka@gmail.com
University of Shizuoka
OSADA Seicha Co.,Ltd.
Profit organization
Shizuoka General Hospital
SBS Shizuoka Health Promotion Center
NO
静岡県立総合病院
2016 | Year | 12 | Month | 21 | Day |
Unpublished
Completed
2016 | Year | 12 | Month | 08 | Day |
2016 | Year | 12 | Month | 08 | Day |
2016 | Year | 12 | Month | 08 | Day |
2018 | Year | 05 | Month | 01 | Day |
2016 | Year | 12 | Month | 21 | Day |
2019 | Year | 06 | Month | 25 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000029176
Research Plan | |
---|---|
Registered date | File name |
Research case data specifications | |
---|---|
Registered date | File name |
Research case data | |
---|---|
Registered date | File name |